Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirin Khan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Psychopharmacology Bulletin|September 10, 2008
Placebo response in depression: a perspective for clinical practiceArif Khan, Shirin Khan
The International Journal of Neuropsychopharmacology|October 9, 2002
Are placebo controls necessary to test new antidepressants and anxiolytics?Arif Khan, Shirin Khan, Walter A Brown
The American Journal of Psychiatry|April 2, 2003
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reportsArif Khan, Shirin Khan, Russell Kolts, et al.
The Journal of Clinical Psychiatry|February 20, 2003
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardationSeth Cohen, Brian Fitzgerald, Anthony Okos, et al.
Journal of Affective Disorders|June 14, 2002
Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA databaseArif Khan, Robyn M Leventhal, Shirin Khan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2017
Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013Arif Khan, Kaysee Fahl Mar, Jim Faucett, et al.
The Journal of Pediatrics|July 9, 2020
Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and TestingLaura Avila, Nour Amiri, Paul Yenson, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|July 6, 2026
From inflammation to inheritance: rethinking myocarditis as the first signal of desmosomal cardiomyopathyAntoine Fakhry AbdelMassih, Anna Carinina Sankari, George Mallouka, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Psychopharmacology Bulletin|September 10, 2008
Placebo response in depression: a perspective for clinical practiceArif Khan, Shirin Khan
The International Journal of Neuropsychopharmacology|October 9, 2002
Are placebo controls necessary to test new antidepressants and anxiolytics?Arif Khan, Shirin Khan, Walter A Brown
The American Journal of Psychiatry|April 2, 2003
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reportsArif Khan, Shirin Khan, Russell Kolts, et al.
The Journal of Clinical Psychiatry|February 20, 2003
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardationSeth Cohen, Brian Fitzgerald, Anthony Okos, et al.
Journal of Affective Disorders|June 14, 2002
Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA databaseArif Khan, Robyn M Leventhal, Shirin Khan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2017
Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013Arif Khan, Kaysee Fahl Mar, Jim Faucett, et al.
The Journal of Pediatrics|July 9, 2020
Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and TestingLaura Avila, Nour Amiri, Paul Yenson, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|July 6, 2026
From inflammation to inheritance: rethinking myocarditis as the first signal of desmosomal cardiomyopathyAntoine Fakhry AbdelMassih, Anna Carinina Sankari, George Mallouka, et al.
Pageof 1